Parameters Predicting Microvascular Invasion and Poor Differentiation in Hepatocellular Carcinoma Patients with Normal Alpha-fetoprotein Level Before Liver Transplantation
暂无分享,去创建一个
B. Carr | E. Samdanci | S. Yılmaz | B. Isik | V. Ince | S. Usta | B. Kilci | Harika G Bağ
[1] Huan Liu,et al. Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma , 2021, Frontiers in Oncology.
[2] S. Yılmaz,et al. The Importance of the Immunosuppressive Regime on Hepatocellular Carcinoma Recurrence After Liver Transplantation , 2021, Journal of Gastrointestinal Cancer.
[3] S. Kubo,et al. The Prognostic Impact of Tumor Differentiation on Recurrence and Survival after Resection of Hepatocellular Carcinoma Is Dependent on Tumor Size , 2021, Liver Cancer.
[4] Lequn Li,et al. S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma , 2021, Hepatology International.
[5] B. Carr,et al. Liver Transplantation for Hepatocellular Carcinoma: Malatya Experience and Proposals for Expanded Criteria , 2020, Journal of Gastrointestinal Cancer.
[6] K. McGlynn,et al. The Changing Epidemiology of Primary Liver Cancer , 2019, Current Epidemiology Reports.
[7] Zhe Yang,et al. Lower mean platelet volume is a risk indicator of hepatocellular carcinoma recurrence following liver transplantation. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.
[8] B. Carr. Review of therapies for intermediate and advanced stage hepatocellular carcinoma, not suitable for curative therapies: a rapidly changing landscape , 2019, Hepatoma research.
[9] J. Tu,et al. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage , 2019, Pathology & Oncology Research.
[10] B. Győrffy,et al. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma , 2018, Royal Society Open Science.
[11] S. Bota,et al. Association of platelet count and mean platelet volume with overall survival in patients with cirrhosis and unresectable hepatocellular carcinoma , 2018, Zeitschrift für Gastroenterologie.
[12] S. Terai,et al. Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers , 2018, Oncotarget.
[13] A. Kahraman,et al. Liver Transplantation for Hepatocellular Carcinoma at Inonu University , 2017, Journal of Gastrointestinal Cancer.
[14] H. Baba,et al. Predictive factors of pathological vascular invasion in hepatocellular carcinoma within 3 cm and three nodules without radiological vascular invasion , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.
[15] M. Ferrario,et al. Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach , 2016, Scientific Reports.
[16] H. Moch,et al. Intratumor Heterogeneity in Hepatocellular Carcinoma , 2014, Clinical Cancer Research.
[17] Jian-Bing Fan,et al. Gene-expression signature of vascular invasion in hepatocellular carcinoma. , 2011, Journal of hepatology.
[18] K. Kaneko,et al. Preoperative predictors of vascular invasion in hepatocellular carcinoma. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[19] K. Sung,et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large‐volume center , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[20] Timothy M Pawlik,et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[21] ndrea,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[22] B. Carr,et al. Microscopic vascular invasion by hepatocellular carcinoma in liver transplant patients. , 2020, Clinical practice.
[23] B. Carr,et al. HCC with low- and normal-serum alpha-fetoprotein levels. , 2018, Clinical practice.
[24] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.